OCGN Ocugen Inc

$OCGN new 7 month update from a EAP patient. We own a literal cure to blindness about to hit the market. This is what matters, not just for humanity but for investors too, everything else is just noise by comparison. 🍻

$OCGN there will be a large announcement in the first week of November. They chose October 30th as the date of record for a reason, to allow large investors to stock up on the stock. They will be able to then pass the agreement. I will stick around for the good times. This will reach $2.50 befoe Decemebr 22nd and then $4 before the end of the year!!!

$OCGN Basically the same exact pattern as 2024-25. Looking to find support at 0.886 fib and the RSI hitting the purple line (30), which has always caused a positive reversal.

$OCGN Wow …. The clientele on here have gone downhill!! … just having a beer . 😎🍺😎 ABSOLUTELY BULLISH

$OCGN Tough week especially today with Biotechs across the board getting whacked we've got 2 months till the outcome of the vote we've got a potential game changing treatment P3 data for RP about to be dropped I've came to far to turn back all or nothing ride or die or whatever it's called here to the end 💯

$OCGN I added 2,000 shares, for a total of 210k. Do you think that’s enough for retirement, or should I buy more shares next week?🤩

$OCGN Ocugen is at a price that, in my opinion, is absolutely crazy. Maybe I’m crazy too, but I sold some other positions where I was already in profit and used the money to buy another $5K of Ocugen. This price seems incredible to me. I honestly think this could be an opportunity we may never see again.

$OCGN Just taking out retail as institutions add. Been down this road before. This stock is not for the faint at heart! Long and strong!

$OCGN You have to understand that companies like Roots Pharmaceuticals don’t just sign licensing agreements blindly. Before entering into these partnerships, pharmaceutical companies typically conduct commercial and scientific due diligence, reviewing the available data, development plans, and market potential. They are also putting their own money and reputation on the line. The fact that companies are choosing to partner with Ocugen and secure rights to its treatments is a positive signal that there is genuine interest in the technology and its potential. Of course, this doesn’t guarantee successful clinical trial results, but we shouldn’t ignore the fact that professional pharmaceutical companies carry out their own assessments before committing resources to a project. There’s a difference between simply hoping something will work and being willing to invest in its potential.

$OCGN I’m bullish because OCGN’s price already seems to price in a very pessimistic outcome. Even the dilution vote feels largely priced in. If OCU400 delivers strong data, the market could revalue the stock sharply. That’s why, at these levels, I see an attractive risk/reward.

$OCGN im loading up while I can. A few more decent buys before end of year then sitting and waiting. My guess is q1 or q2 2027 we'll lift off hard.

$OCGN Farmer is correct, the stock isn't gonna fly on good results without a clear financial runway, you no vote pricks are causing uncertainty and welcoming this short attack. Are you assholes having fun with the shit show you've created?

$OCGN https://www.sec.gov/Archives/edgar/data/1372299/000110465926115970/tm2627592d2_ex99-1.htm This presentartion should become viral 🔥 Great opportunity at this price, Phase 3 Ocu400 only 5 months ahead

$OCGN just watched the entire thing on you tube…wow. 7 months in and he is doing great and vision improving. Worth the watch. Let’s get this done and get this treatment approved! Extremely

$OCGN Partner distribution announcement seems positive, with the positive data released last week. The negativity drummed up over the CEO seems be doing the job on the SP with a lot of retail holders freaking out across numerous online platforms. But I’m staying for the science and the data, one of them will hit, if all 3 do which is a longish shot then happy days,only gamble with what you can afford to lose.👍🏻

$OCGN 32% short interest, 76% short volume, 68% volume off exchange, RSI below 30, still NASDAQ compliant, still pipeline on track with cash for another year. MM's found their moment they had been waiting for to catch the weakest moment. Been here seen it. A company nasdaq incompliant thrice in past 6 years always finds a way to bounce back. We are 5-6 months to the judgement day. FUD is at peak today, low volume and manipulation at its finest from MM's and algos. Keep shaking the tree like many times before. Hold it. Last check point for bulls in this roller coaster.

$OCGN · $OPHLF 🤝 Ocugen and Roots Pharmaceutical completed a license agreement for OCU400 modifier gene therapy for retinitis pigmentosa in the Middle East and North Africa, including upfront and initial development payments up to $4 million, potential sales milestones up to $255 million, 22% royalties on net sales, and Ocugen manufacturing and supply. Prioritized by relevance

$OCGN simple analysis shows that you NO voters aren’t capable of understanding basic concepts. Perhaps too many of you are simple minded puppets who learned how to buy and sell shares, never having a clue why you bought OCGN shares, much less who what where was this company the moment you bought. I don’t see too many idiotic bearish posts bc I block anything that destroys brain cells. But you’re kind is a contagion virus 🦠 that loves company. Happy? Your vote proves you’re imbeciles getting what was expected. Now that I got that off my chest, I get back to doing my daily shores, at peace with the fact that I have to live around so many of you. To the rest of the good people here, Have a Blessed Day 🌞📸💛

$OCGN I honestly think these prices are a bargain. I’m continuing to buy a little every day and gradually building my position. At these levels, I’m happy to keep averaging in rather than trying to guess the exact bottom. 🚀

$OCGN There is nothing for any retail purchaser to worry about besides keep buying at these ridiculous low levels and turning off your share lending. Since we hit the Russel the short houses are able to borrow your shares at 3% to short. The shorts are now winning at 32.87% & institutional ownership is at 47.93%. Corruption at its finest. Once amazing phase 3 results hit by March of 2027 this will launch with hopefully a massive short squeeze beyond expectations. Just keep accumulating till then. Ocugen is an incredible company with a pipeline beyond most Big Pharma Company today. Paytience Pays…